Medical Research

Clinical Trials Public Health Patient Care Research Health Policy Infectious Diseases Vaccines Clinical Studies Global Health Clinical Studies

FDA to Decide on Twice-Yearly HIV Preventive Drug Lenacapavir

Generic manufacturers are set to produce lenacapavir for as little as $25 per patient annually

Stories older than 24h

Eli Lilly to Acquire Verve Therapeutics in $1.3 Billion Gene-Editing Deal

Gestational Hypertension Linked to Elevated Seizure Risk in Children

Deep Learning Study Exposes Global Rise and Inequalities in Rheumatoid Arthritis Burden

RFK Jr. Reconstitutes ACIP as CDC, FDA Narrow COVID-19 Vaccine Recommendations

RFK Jr. Replaces CDC Vaccine Experts With Skeptical Appointees

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

Caffeine Could Offer New Defense Against Sudden Infant Death Syndrome

Tufts Develops Biodegradable Dental Implants That Aim to Restore Sensation

Texas Allocates $50 Million for Ibogaine Treatment Research

Parkinson’s Symptom Asymmetry Shapes Vocal Emotion Recognition

Trump Administration Cuts Moderna Funding and Disbands mRNA Vaccine Panel

COVID-19 Survivors Regain Physical Health in Three Months but Face Prolonged Mental Recovery

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

Hayward Fire Department Secures MRI Partnership to Detect Cancer Early Among Firefighters

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions

Lung-Targeted Nanoparticles Deliver Genetic Therapies to Treat Cancer and Cystic Fibrosis

Three-Year Exercise Program Cuts Colon Cancer Recurrence and Deaths, Study Shows

Colorectal Cancer Survivors Face Long-Term Sexual Health Risks